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 INTRODUCTION
 Over the past two decades, the medical armamentarium for the 
treatment of Crohn’s disease (CD) has expanded dramatically 
( 1–3 ). However, surgery continues to play a pivotal role in the 
treatment of CD, particularly for patients with aggressive pen-
etrating phenotype, fi brostenotic obstructions, or disease refrac-
tory to medical therapy ( 4 ). In a meta-analysis, nearly half of CD 
patients required a surgical resection within 10 years of diagnosis 
and 35% needed a second operation within the next decade ( 5,6 ). 
Approximately one-third of persons undergoing surgery for CD 
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will develop postoperative complications ( 7,8 ). Th e cost of sur-
gery and associated hospitalizations contributes to the high direct 
healthcare costs associated with CD management ( 9 ).
 CD patients typically undergo intestinal resections in one of two 
settings: (a) elective operations that occur due to lack of effi  cacy 
of outpatient medical therapies or (b) emergent operations occur-
ring because of acute or life-threatening complications (e.g., small 
bowel obstruction) or failure of rescue inpatient medical treat-
ment. Th is distinction is important because patients undergoing 
emergency surgery are more likely to experience postoperative 
complications and postoperative mortality ( 2,10 ).
 Temporal changes in the incidence of CD-related surgery are 
controversial. Although a meta-analysis of population-based stud-
ies suggests a decreasing incidence of surgery over the past sev-
eral decades ( 5 ), studies derived from administrative databases 
have reported confl icting results ( 11–13 ). Th ese diff erences may 
be a refl ection of study design, particularly because results derived 
from administrative data rely heavily on the selection and validity 
of administrative coding ( 14 ). In many jurisdictions, the Interna-
tional Classifi cation of Disease (ICD)-10 has now been introduced 
to more comprehensively capture clinical data. Although this cod-
ing system has been expanded from previous editions, it has not 
yet been validated for hospitalized patients with CD.
 Th us, we conducted a population-based study to evaluate tem-
poral trends in surgical rates for CD stratifi ed by the setting of 
surgery. We fi rst performed a detailed validation of ICD-10-CM 
coding for CD diagnosis among hospitalized patients and admin-
istrative coding for surgical bowel resections. We then used the 
validated codes to defi ne surgical resection rates over time in this 
population.
 METHODS
 Data source
 Th e Data Integration, Measurement and Reporting (DIMR) 
discharge abstract administrative database captures all hospi-
talizations in the Calgary Health Zone (CHZ) of Alberta Health 
Services, Canada. Th e Calgary Health Zone is a population-
based health authority under a public, single payer system, with 
an estimated catchment population of 1.4 million in 2011 ( 15 ). 
Geographically, the CHZ covers over 39,300 km 2 and includes a 
large urban metropolis as well as multiple suburban communities 
and smaller rural towns and villages. Th is area is serviced by 56 
gastroenterologists and eight colorectal surgeons, working out of 
four large tertiary care medical centers. Th e DIMR database cap-
tures 42 diagnostic codes (based on International Classifi cation of 
Disease, 10th Revision, Clinical Modifi cation) and 25 procedural 
codes (based on Canadian Classifi cation of Health Intervention 
(CCI) coding). CCI coding is based on an alphanumeric struc-
ture with six fi eld codes specifying the type of intervention (e.g., 
diagnostic vs. therapeutic), anatomy (e.g., large vs. small bowel), 
type of procedure (e.g., partial vs. total resection), and qualify-
ing conditions (e.g., procedure approach and technique used to 
perform the intervention). Th e CHZ transitioned to ICD-10-CM 
diagnostic coding from ICD-9 in 2002.
 Part 1—validation of ICD-10-CM and CCI coding
 We fi rst validated ICD-10-CM coding for CD diagnosis among 
hospitalized patients and CCI coding for surgical resections. Pop-
ulation-based surveillance was conducted in the CHZ between 
January 1 and December 31, 2011 to identify all adults (≥18 
years) admitted to hospital with a diagnostic code for CD (ICD-
10-CM K50.X). All patients with CD who underwent an intes-
tinal resection in 2011 were included for the validation study. A 
negative control population was created by randomly sampling 
200 patients with CD who were admitted to hospital but did not 
undergo an intestinal resection surgery. We validated administra-
tive coding for 2011 because hospital records (including discharge 
summaries and operative reports) became available electronically 
aft er this time; using the electronic records allowed for more accu-
rate capture of surgical procedures and hospitalization details for 
validation.
 Surgical resection codes were defi ned  a priori and stratifi ed by 
CCI group: partial small intestine excisions including ileocecal 
resection (1.NK.87), partial large intestine excision (1.NM.87), 
total large intestine excision including total abdominal colectomy 
(1.NM.89, 1.NM.91), partial rectal excision including rectosig-
moid resection (1.NQ.87), and total rectal excision including 
proctocolectomy (1.NQ.89). We specifi cally wanted to capture 
intestinal resection surgeries. We excluded relatively less invasive 
procedures with a lower burden of patient morbidity, including 
endoscopic procedures, “second-step” operations (e.g., pouch 
formation, completion proctectomy, ileostomy reversal), isolated 
perianal surgery, and abscess drainage. A complete list of admin-
istrative codes included and excluded from this study are found in 
 Supplementary Tables 1 and 2 .
 Administrative database codes were then validated against 
comprehensive chart review for CD diagnosis, disease location 
(small intestine, large intestine, small and large intestine), surgi-
cal urgency (elective vs. non-elective), surgical approach (open vs. 
laparoscopic), and post-surgical anatomy (primary anastomosis 
vs. stoma). Surgery was defi ned as elective if the decision to oper-
ate was made prior to hospital admission. In contrast, the decision 
for emergent or urgent surgery occurred during the admission 
(e.g., aft er non-response to medical therapy or in response to life-
threatening CD complications). Laparoscopic surgery requiring 
intra-operative conversion to open approach was classifi ed as an 
open laparotomy.
 For validation of administrative coding for CD diagnosis among 
hospitalized patients and for surgical resection, sensitivity, speci-
fi city, positive predictive value (PPV), and negative predictive 
value (NPV) with 95% confi dence intervals (CIs) were calculated.
 Part 2—CD surgical rates
 Using validated ICD-10-CM diagnostic codes and CCI surgical 
resection codes, the DIMR database was used to identify all adults 
admitted to hospital with a diagnostic code of CD and undergo-
ing surgical bowel resection between fi scal years 1 April 2002 and 
31 March 2011. Data beyond 2011 were not available for analysis. 
Analysis was restricted to patients living within the CHZ to mini-
mize uncaptured surgical resections occurring at hospitals outside 
© 2017 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
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the CHZ. Patients with codes for both CD and ulcerative colitis 
were excluded. Multiple admissions occurring within a 12-month 
period were counted as a single operation. Th is restriction was 
applied to prevent double counting of multi-stage operations. 
Rate of stricturoplasties was assessed in a sensitivity analysis. 
Perianal surgery in isolation (i.e., without intestinal resection or 
partial rectal excisions) and abscess drainage were excluded.
 Annual surgical rates were calculated by dividing the annual 
surgical incident cases by the corresponding prevalence of CD in 
the CHZ. Th e prevalence of CD in CHZ from fi scal years 1997 
to 2009 was derived from a previous study ( 16 ). For fi scal year 
2010, the prevalence of CD was forecast using double exponen-
tial smoothing of data from fi scal years 1997 to 2009. Time trend 
analysis was performed on surgical rates by calculating the annual 
percent change (APC) using a generalized linear model that 
assumed a Poisson distribution. A negative binomial distribution 
was assumed when the data was over-dispersed. APCs were not 
statistically signifi cant when the 95% CI crossed 0. Th e analysis 
was subsequently stratifi ed by elective vs. non-elective surgical 
urgency, age at surgery (18–34, 35–64, and ≥65 years), and type of 
anatomic resection (small bowel vs. large bowel). Joinpoint regres-
sion was used to assess for statistical infl ection points in the tem-
poral trends.
 Statistical analyses were performed using SAS version 9.4 (SAS 
Institute Inc., Cary, NC, USA) and Joinpoint Regression Program 
4.0.1 (Statistical Research and Applications Branch, National 
Cancer Institute, USA). Th e study was approved by the Conjoint 
Health Research Ethics Board of the University of Calgary and 
was conducted in accordance with the Strengthening of Reporting 
of Observational Studies in Epidemiology (STROBE) statement 
( Supplementary Table 3 ) ( 17 ).
 RESULTS
 Validity of ICD-10-CM CD diagnostic coding
 In our validation cohort, we identifi ed 580 admissions to hospital 
with a diagnostic code for CD (K50.X) in 2011. Among these 580 
admissions, we identifi ed 104 patients with codes for both CD and 
surgical bowel resection. Among those without surgical bowel 
resection, we randomly sampled 200 negative control CD patients 
( Figure 1 ). CD was confi rmed in 101/104 (97.1%) patients under-
going surgical resection compared to 191/200 (95.5%) patients 
admitted but not requiring surgery. Common reasons for mis-
classifi cation were ischemic colitis or other infl ammatory bowel 
disease (e.g., ulcerative colitis).
 Validity of individual CD diagnostic codes is summarized in 
 Table 1 . When stratifi ed by disease location, sensitivity for small 
bowel, large bowel, and ileocolonic CD was variable (range 0.30–
0.95) but highly specifi c (range 0.87–0.99). Administrative data-
base coding was highly predictive of small bowel (PPV 0.90 (95% 
CI: 0.8, 0.95)) and large bowel CD (PPV 0.90 (95% CI: 0.76, 0.97)). 
Th e administrative database identifi ed 127 patients with a diag-
nostic code of K50.9 (CD, unspecifi ed); this was more commonly 
identifi ed in the negative control cohort (109/127, 85.9%) whereas 
only 18 (14.2%) CD patients undergoing surgery had unspecifi ed 
disease location. When K50.8 and K50.9 codes are pooled, the 
combined sensitivity for ileocolonic disease increases (0.91 (95% 
CI: 0.83, 0.94)) but becomes less specifi c (0.59 (95% CI: 0.51, 0.67)).
 Validity of CCI CD surgical coding
 On chart review, 113 resections were confi rmed among 116 surgi-
cal resection codes (97.4%), performed in 104 separate patients 
in 2011 ( Table 2 ). Predominantly, these were partial small bowel 
resections (58/113, 51.3%). Overall, procedural coding was highly 
accurate for identifying patients undergoing partial small bowel 
resections (PPV 0.87 (95% CI: 0.75, 0.94)) and partial large bowel 
resections (PPV 0.81 (95% CI: 0.64, 0.91)). Procedural coding 
also accurately identifi ed patients undergoing total abdominal 
colectomy (PPV 1.00 (95% CI: 0.40, 1.00)), total proctocolectomy 
(PPV 0.86 (95% CI: 0.42, 0.99)), and partial rectal resections (PPV 
0.80 (95% CI: 0.30, 0.99)), although this was based on limited 
sample size.
 Procedural qualifi er codes were validated for surgical approach 
and post-surgical anatomy ( Table 3 ). Th e sensitivity of adminis-
trative coding for elective vs. non-elective surgery and open vs. 
laparoscopic surgical approach exceeded 85%. Six laparoscopic 
procedures were misclassifi ed: in 2/6 cases (33.3%) misclassifi ca-
tion was due to conversion from initial laparoscopic approach to 
open laparotomy. Th e administrative database accurately identi-
fi ed post-surgical anastomosis (PPV 0.98 (95% CI: 0.92, 1.00)) and 
stoma formation (PPV 0.86 (95% CI: 0.64, 0.96)).
 Surgical rates
 Th ere were 981 surgical resections performed between fi scal years 
2002 and 2010 across the CHZ, with an average surgical incidence 
of 3.8 operations per 100 person-years. Th e overall rate of surgery 
decreased by 3.5% per year (95% CI: −5.8%, −1.0%), from 4.4/100 
person-years in 2002 to 3.5/100 person-years in 2010 ( Figure 2 ).
 When stratifi ed by surgical setting, non-elective surgeries 
decreased signifi cantly by 10.1% per year (95% CI: −13.4%, −6.7%). 
Indeed, the rate of non-elective surgery was halved between fi scal 
years 2002 and 2010 (2.9 vs. 1.4 per 100 person-years). In contrast, 
there was a statistically signifi cant increase in incidence of elec-
tive surgeries by 3.7% per year (95% CI: 0.1%, 7.3%). On joinpoint 
regression, this trend was driven by increasing rates of elective 
surgeries from 2002 to 2007 (APC 11.3% (95% CI: 9.3%, 13.2%, 
 P <0.001)), aft er which time elective surgery incidence stabilized 
(APC −5.4% (95% CI: −12.6, 2.4%,  P =0.17)). Th ere was no statis-
tically signifi cant joinpoint for emergent operations. At the start 
of the study period, the non-elective surgery rate was more than 
double that of elective surgeries (2.9 vs. 1.4 per 100 person-years). 
However, these rates equalized by 2005 and in the fi nal year, rate 
of elective surgery exceeded that of non-elective operations (2.0 vs. 
1.4 per 100 person-years).
 Th e incidence of partial small bowel resection (includes ileoce-
cal resection), was stable during the study period (APC −2.2% 
(95% CI: −5.3%, 1.0%)). However, partial colonic resections sig-
nifi cantly decreased by 8.5% per year (95% CI: −13.2%, −3.5%). 
Total abdominal colectomy or proctocolectomy rates were stable 
(APC 1.1% (95% CI: −7.1%, 10.1%)). Surgery was most commonly 
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performed in patients with CD between the ages of 18 to 34 years 
(annual incidence 5.0 per 100 person-years) and surgical rates 
were stable in this age group (APC −2.2% (95% CI: −6.7%, 2.4%)). 
In contrast, patients with CD≥65 years experienced the greatest 
decline in annual surgical incidence rates (APC −12.8% (95% CI: 
−20.0%, −5.1%)) ( Table 4 ).
n = 580
n = 104 n = 200
Randomly selected
Negative control cohort:
Admission with CD diagnostic code
but without CD-related intestinal
resection CCI codes
CD-related resection CCI codes:
1.NK.87 - excision partial, small intestine
1.NM.87 - excision partial, large intestine
1.NQ.87 - excision partial, rectum
1.NQ.89 - excision total, rectum (including
proctocolectomy)
1.NM.89 - excision total, large intestine
Crohn’s disease (CD) ICD-10-CA codes:
K50.0 - CD of small intestine
K50.1 - CD of large intestine
K50.8 - CD of small and large intestine
K50.9 - CD unspecified (regional enteritis NOS)
Inpatient Discharge Abstract Database
2011 - Calgary Health Zone
 Figure 1 .  Identiﬁ cation of surgical intestinal resection validation cohort and negative control cohort from the Data Integration, Measurement and Reporting 
Discharge Database (2011).
 
 Table 1 .  Validation of diagnostic codes by location of disease for hospitalized patients with Crohn’s disease 
 Diagnostic codes a  Deﬁ nition  Sensitivity (95% CI)  Speciﬁ city (95% CI)  PPV (95% CI)  NPV (95% CI) 
 CD patients undergoing surgical resection 
 K50.0  Crohn’s disease of the small intestine  0.70 (0.54, 0.82)  0.90 (0.78, 0.96)  0.84 (0.68, 0.93)  0.79 (0.67, 0.88) 
 K50.1  Crohn’s disease of the large intestine  0.95 (0.74, 0.99)  0.99 (0.93, 1.00)  0.95 (0.74, 1.00)  0.99 (0.93, 1.00) 
 K50.8  Crohn’s disease of the small and 
large intestine 
 0.53 (0.35, 0.70)  0.87 (0.76, 0.94)  0.67 (0.46, 0.83)  0.79 (0.68, 0.87) 
 CD patients admitted without surgery 
 K50.0  Crohn’s disease of the small intestine  0.53 (0.41, 0.65)  0.98 (0.93, 0.99)  0.92 (0.79, 0.98)  0.78 (0.71, 0.84) 
 K50.1  Crohn’s disease of the large intestine  0.43 (0.28, 0.59)  0.97 (0.93, 0.99)  0.82 (0.59, 0.94)  0.87 (0.80, 0.91) 
 K50.8  Crohn’s disease of the small and 
large intestine 
 0.30 (0.20, 0.41)  0.97 (0.92, 0.99)  0.89 (0.69, 0.97)  0.66 (0.59, 0.73) 
 CD, Crohn’s disease; CI, conﬁ dence interval; NPV, negative predictive value; PPV, positive predictive value. 
 a K50.9 (Crohn’s disease, unspeciﬁ ed) not included because this diagnostic code does not specify disease location. 
© 2017 by the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
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highlight a fundamental paradigm shift  in the surgical manage-
ment of CD during the fi rst decade of the 21st century, with a 
greater emphasis towards an ambulatory model of care.
 A reduction in emergent operations is ideal because CD patients 
who require an emergent procedure have an increased risk of in-
hospital postoperative morbidity ( 18 ), 90-day readmission ( 19 ), 
and most importantly, postoperative mortality ( 2,10 ). In a meta-
analysis of 75,971 CD patients, Singh  et al. found a 6-fold diff er-
ence in postoperative mortality for patients undergoing elective as 
compared to emergent surgery (0.6 vs. 3.6%) ( 2 ). Th us, the evolu-
tion of surgical management towards more elective procedures is 
an important achievement in the care of CD patients.
 Despite the increase in elective operations, there was an over-
all decrease in the surgical resection rates in our cohort that 
mirrors the fi ndings from other population- and cohort-based 
studies ( 12,20–22 ). Our study was not designed to determine fac-
tors leading to the decrease in surgical incidence. Importantly, our 
administrative database lacked medication data that would allow 
us to correlate drug utilization to surgical rates. However, several 
authors have previously attributed the decrease in surgical rates to 
increased adoption of immunosuppressive agents ( 12,20,23 ) and 
 In a sensitivity analysis, 59 stricturoplasty procedures (47/59, 
79.6% small bowel) were identifi ed in the administrative data 
between 2002 and 2010. Th e rate of stricturoplasties decreased by 
7.1% per year, although this trend did not meet statistical signifi -
cance (95% CI: −18.8%, 6.4%,  P =0.20) with no identifi able join-
point.
 DISCUSSION
 In this large population-based cohort study, we fi rst validated 
administrative database coding in hospitalized CD patients: spe-
cifi cally, ICD-10-CM coding is highly predictive of CD diagnosis 
among patients requiring hospitalization or surgery, while proce-
dural coding accurately identifi es surgical resections and surgical 
setting. Th ese validated codes can serve as a reference for future 
administrative database research in this fi eld. We subsequently 
demonstrate using validated administrative coding that the rate of 
intestinal resection for CD decreased by 3.5% per year from 2002 
to 2010. Interestingly, although there was a dramatic decrease in 
emergent surgeries by 10.1% per year, the rate of elective surgeries 
actually increased signifi cantly by 3.7% per year. Th ese fi ndings 
 Table 2 .  Validation of surgical resection procedural codes for patients with Crohn’s disease by site and extent of resection 
 Procedural 
codes 
 Deﬁ nition  Procedures 
Performed ( n , %) 
 Sensitivity 
(95% CI) 
 Speciﬁ city 
(95% CI) 
 PPV (95% CI)  NPV (95% CI) 
 1.NK.87  Excision partial, small intestine  58 (51.3)  0.83 (0.70, 0.91)  0.96 (0.91, 0.98)  0.87 (0.75, 0.94)  0.94 (0.89, 0.96) 
 1.NM.87  Excision partial, large intestine  38 (33.6)  0.79 (0.62, 0.90)  0.96 (0.92, 0.98)  0.81 (0.64, 0.91)  0.96 (0.91, 0.98) 
 1.NM.89  Excision total, large intestine  5 (4.4)  0.80 (0.30, 0.99)  1.00 (0.98, 1.00)  1.00 (0.40, 1.00)  1.00 (0.97, 1.00) 
 1.NQ.87  Excision partial, rectum  5 (4.4)  0.80 (0.30, 0.99)  0.99 (0.97, 1.00)  0.80 (0.30, 0.99)  1.00 (0.97, 1.00) 
 1.NQ.89  Excision total, rectum (including 
proctocolectomy) 
 7 (6.2)  0.86 (0.42, 0.99)  1.00 (0.97, 1.00)  0.86 (0.42, 0.99)  1.00 (0.97, 1.00) 
 CI, conﬁ dence interval; NPV, negative predictive value; PPV, positive predictive value. 
 Table 3 .  Validation of surgical resection procedural codes for patients with Crohn’s disease by approach, urgency, and anastomosis type 
 Procedure type  Procedures Performed 
( n , %) 
 Sensitivity (95% CI)  Speciﬁ city (95% CI)  PPV (95% CI)  NPV (95% CI) 
 Surgical approach 
 Open Approach  78 (69.0)  0.86 (0.76, 0.92)  0.98 (0.95, 0.99)  0.93 (0.84, 0.97)  0.92 (0.86, 0.96) 
 Laparoscopic  35 (30.1)  0.86 (0.69, 0.95)  0.98 (0.96, 1.00)  0.88 (0.72, 0.96)  0.97 (0.93, 0.99) 
 Surgical urgency 
 Elective surgery  73 (64.6)  0.85 (0.74, 0.92)  0.98 (0.95, 0.99)  0.94 (0.84, 0.98)  0.93 (0.87, 0.96) 
 Non-elective surgery  40 (35.4)  0.88 (0.72, 0.95)  0.96 (0.92, 0.98)  0.76 (0.61, 0.87)  0.97 (0.93, 0.99) 
 Post-surgical anatomy a 
 Anastamosis  90 (80.4)  0.89 (0.80, 0.94)  0.99 (0.97, 1.00)  0.98 (0.92, 1.00)  0.99 (0.97, 1.00) 
 Stoma  22 (19.4)  0.86 (0.64, 0.96)  0.99 (0.97, 1.00)  0.86 (0.64, 0.96)  0.98 (0.95, 1.00) 
 CI, conﬁ dence interval; NPV, negative predictive value; PPV, positive predictive value. 
 a Post-surgical anatomy not deﬁ ned in one case by chart review. 
The American Journal of GASTROENTEROLOGY    www.nature.com/ajg
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in randomized controlled trials, anti-TNF therapy is associated 
with decreased risk of surgery in CD ( 24,25 ).
 Non-medication related factors may also explain the observed 
reduction in surgery. Th e management of CD has become increas-
ingly complex. However, evolving practice patterns have led to 
earlier disease detection, closer endoscopic and radiographic 
follow-up, targeting of complete mucosal healing as a treatment 
outcome, and improved access to tertiary level IBD care. For exam-
ple, Nguyen  et al. demonstrated reduced 5-year surgical risk in CD 
patients in association with increased access to specialist gastroen-
terologists ( 21 ). Improved access to gastroenterology consultation 
may result in improved therapeutic decision-making early in the 
disease course or during hospitalizations, preventing emergency 
surgery. Furthermore, the implementation of clinical decision 
tools and treatment algorithms have streamlined the manage-
ment of complex CD and highlighted important quality indicators 
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 Figure 2 .  Decreasing annual surgical resection rates for Crohn’s disease from ﬁ scal years 2002 to 2010 in the Calgary Health Zone. Resection rates strati-
ﬁ ed by elective (blue) vs. non-elective surgeries (red).
 
 Table 4 .  Trends in Crohn’s disease related bowel resection rates 
 Surgery subgroup  Average incidence of surgery 
(per 100 person-years) 
 APC (95% CI)  P -value 
 All surgeries ( n =981) a  3.8  −3.5% (−5.8%, −1.1%)  0.004 
 Non-elective surgeries ( n =489)  1.9  −10.1% (−13.4%, −6.7%)  <0.001 
 Elective surgeries ( n =492)  1.9  3.7% (0.1%, 7.3 % )  0.042 
 Partial small bowel resection ( n =572)  2.2  −2.2% (−5.3%, 1.0%)  0.169 
 Partial colonic resection ( n =349)  1.4  −8.5% (−13.2%, −3.5%)  0.001 
 Partial rectal resection ( n =35)  0.1  12.7 (−8.4, 38.7)  0.258 
 Total abdominal colectomy ( n =37)  0.1  −4.3% (−15.7%, 8.7%)  0.499 
 Total abdominal colectomy or total proctocolectomy ( n =88)  0.3  1.1% (−7.1%, 10.1%)  0.798 
 Age 18–34 (all surgeries) ( n =346)  5.0  −2.2% (−6.7%, 2.4%)  0.342 
 Age 35–64 (all surgeries) ( n =548)  3.4  −2.1% (−5.3%, 1.1%)  0.193 
 Age 65+ (all surgeries) ( n =86)  3.3  −12.8% (−20.0%, −5.1%)  0.002 
 APC, annual percent change; CI, conﬁ dence interval. 
 a Sum of surgical resections performed exceeds total surgeries ( n =981) because some patients were coded for more than one procedure. This was counted as a single 
surgery in the total cohort for trend analysis. 
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 Interestingly, other authors studying the trend in incident sur-
geries for CD using administrative data have reported confl icting 
results ( 11,13,32–35 ). For instance, in evaluating the Nationwide 
Inpatient Sample, Geltzeiler  et al. reported a 26% increase in 
Crohn’s-related operations from 1988 to 2011 ( 13 ). Although pre-
cise estimates for the comparable time period from 2002 to 2010 
are not specifi ed, the authors present a linear regression model 
assuming a constant increase of approximately 1% per year in the 
number of surgical procedures performed. However, the authors 
report only the crude number of operations performed and do 
not account for the increase in incidence of IBD ( 36 ). Further, the 
Nationwide Inpatient Sample is a discharge abstract database that 
cannot diff erentiate repeat admissions of the same patient, which 
could lead to overinfl ating surgical rates. Data from Europe is also 
available for comparison: Burke  et al. evaluated Crohn’s-related 
surgeries between 2000 to 2010 in the Republic of Ireland, dem-
onstrating stable rates of small bowel and right colon procedures, 
decreasing rates of left  colon surgeries, but increasing rates of 
total colectomy ( 32 ). However, these rates were calculated using 
the total estimated adult Irish population from census data as the 
denominator and do not account for the higher relative increase 
in IBD prevalence. Further, diff erences in biologic use, surgical 
and medical care, or patient preferences for treatment may also 
account for the diff erences observed compared to our population.
 Th ere are several limitations to our study. First, administrative 
databases lack information on important factors that may have 
infl uenced surgical rates such as tobacco use and symptom bur-
den. We were also unable to classify disease behavior to determine 
whether changes in surgical rates were specifi c to stricturing or 
penetrating disease phenotypes and the administrative database 
did not capture CD duration. Second, all studies performed using 
administrative data are subject to misclassifi cation bias. Although 
we minimized this by validating our diagnostic and procedural 
coding, there may be temporal trends in database coding patterns 
and validity that could not be accounted for, particularly if there 
were early errors made when the administrative coding switched 
to ICD-10-CM in 2002. Reassuringly though, there are no early 
joinpoints in surgical rates aft er 2002 that could potentially indi-
cate discrepancies due to coding inexperience. Additionally, 
although we sampled negative control patients for the validation 
cohort, this control cohort may still be undersized in relation to 
CD resection prevalence. Th irdly, we lacked data on drug utiliza-
tion to determine the infl uence of immunomodulators and biolog-
ics on surgical rates for CD. Even if medication data were available, 
theses correlations would still be subject to ecological fallacy. 
Finally, re-validation of the codes should be undertaken in other 
regions to determine whether our fi ndings can be generalized out-
side of a large Canadian health region, particularly in jurisdictions 
where surgical procedures are performed outside of the hospital 
setting in dedicated ambulatory surgery centers. Additionally, our 
validation of ICD-10 codes is specifi cally applicable to hospitalized 
patients but may not be generalizable to the outpatient setting.
 While gastroenterologists and CD patients oft en strive to 
manage disease medically and avoid intestinal resection, surgery 
is crucial in certain clinical settings to achieving disease control. 
for treatment ( 26 ). Th ese non-medication related factors play an 
important role in improving the care of CD patients and poten-
tially, reducing the long-term risk of surgery.
 Th e increase in incidence of elective resections could be 
explained by changes in surgical practice patterns or indications 
for resection. For instance, concerns regarding poor postoperative 
wound healing and infection have resulted in hesitancy among 
some surgeons for operating on CD patients actively treated with 
biologics ( 27 ). Th is may result in postponing surgery to allow drug 
washout and increased rates of planned or staged elective opera-
tions. Additionally, we observed the greatest decline in surgical 
incidence among elderly patients. Traditionally, this is a group of 
patients with milder infl ammatory disease activity but a higher 
burden of comorbidities and operative risk ( 28 ). Th is may discour-
age surgery as a therapeutic option in this cohort, particularly for 
smoldering disease.
 Administrative databases provide a cost- and time-effi  cient 
method for studying epidemiologic and health system trends com-
pared to retrospective cohort studies. However, results must be 
interpreted in the context of the validity of administrative coding. 
Many coding algorithms are utilized by diff erent administrative 
databases but ICD-10-CM coding has recently been adopted in the 
United States. In Canada, ICD-10-CM coding has been in use for 
over a decade and in the Calgary Health Zone, discharge admin-
istrative data has been using ICD-10-CM coding since 2002. Th is 
study provides the index validation for ICD-10-CM coding for CD 
diagnosis among hospitalized patients. It can be also used as a ref-
erence for both diagnostic and procedural codes for researchers 
studying this population in the future.
 In our cohort, over 95% of patients with K50.X diagnostic cod-
ing were confi rmed as having CD by chart review. In comparison, 
Th irmurthi  et al. previously validated ICD-9 coding for CD in the 
Department of Veterans Aff airs National Patient Care Database, 
demonstrating a PPV of 88–100% ( 29 ). Our point estimates of 
administrative data accuracy may be higher due to selection bias 
because we only evaluated hospitalized CD patients: this subset of 
patients is more likely to have a confi rmed diagnosis of CD prior 
to invasive surgery and the diagnosis can be verifi ed on opera-
tive pathology. Accuracy of ICD-10-CM coding for CD is likely 
higher than that for ulcerative colitis: in a similar cohort, we have 
demonstrated that patients coded as having ulcerative colitis oft en 
are misclassifi ed on the basis of having colonic CD, but the con-
verse misclassifi cation bias of CD as ulcerative colitis is less likely, 
particularly for Crohn’s ileitis ( 30 ).
 However, the accuracy of predicting CD location based on ICD-
10-CM coding alone remains limited due to low sensitivity. We 
speculate that this is due to incomplete reporting in the primary 
medical record that may be infl uenced by the complex nature of 
the disease or due to progression of disease extent over time. Nev-
ertheless, frequent utilization of the K50.9 administrative code 
(CD, unspecifi ed location) highlights a gap in the quality of cur-
rent diagnostic reporting. Emphasizing the precise description of 
CD extent and location using a standardized classifi cation system 
such as the Montreal Classifi cation ( 31 ) may improve diagnostic 
accuracy moving forwards.
The American Journal of GASTROENTEROLOGY    www.nature.com/ajg
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Ma  et al. 
Th e optimal clinical setting for minimizing postoperative morbid-
ity and mortality is a planned elective surgery aft er consultation 
between the patient, surgeon, and gastroenterologist, working 
together as a multidisciplinary team. Th is large population-based 
cohort study serves as the index study for validating ICD-10-CM 
coding for CD in hospitalized patients and supports the transition 
to ICD-10-CM coding in many jurisdictions. Using these validated 
codes, we demonstrate an overall decline in surgical resection 
rates for CD, but more importantly we highlight a fundamental 
paradigm shift  whereby emergent surgeries have dramatically 
decreased with a parallel increase in operations occurring in the 
elective setting. Future studies are necessary to delineate medi-
cal and non-medical factors that have contributed to this change 
in surgical management and to further elucidate the continuing 
evolution of these trends. Surgical rates aft er 2010 will likely be 
infl uenced not only by the continually expanding medical arma-
mentarium for CD treatment, but also new concepts in manage-
ment including the integration of primary care networks, rigorous 
therapeutic drug monitoring, and treatment-to-target of both 
symptoms and possibly objective endoscopic, radiographic, histo-
logic, and biomarker outcomes.
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 Study Highlights
 WHAT IS CURRENT KNOWLEDGE 
 ✓  Crohn’s disease patients are at high risk for requiring 
surgical bowel resection. 
 ✓  Emergent surgical resection is associated with an 
increased risk of postoperative complications and mortality. 
 ✓  Many jurisdictions including the United States are shifting 
from ICD-9 to ICD-10-CM coding in administrative data-
bases. 
 WHAT IS NEW HERE 
 ✓  From 2002 to 2010, there has been an overall decrease in 
surgical resection rates among Crohn’s disease patients. 
 ✓  This decrease is driven predominantly by reductions in 
emergency surgery rate while the rate of elective surgery is 
increasing. 
 ✓  This study provides the index validation of ICD-10-CM 
coding for patients with Crohn’s disease requiring hospitali-
zation or surgery. 
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